USPTO 2015–2025 USPTO PatentsView US Corporation

Molecule Works Inc.

USPTO PatentsView assignee record - 13 granted patents across 18 technology areas, recorded in grant years 2020–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01D (Separation).

RSS updates for this company

The verdict

According to USPTO PatentsView, Molecule ranks #21,469 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 18 technology areas.

#21,469
of 49,997 US assignees by volume
Top 23%
by Innovation Score (45.3/100)
17.5
avg claims per patent

USPTO PatentsView assignee plate

Corpus R21469 · US Corporation #21,469 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 13 grants
  • MID-PACK #21,469/49,997
  • PHOTO-FINISH Mitsubishi Chemical UK
  • CPC-FOCUS B01D · 18 areas
  • INNOV-PAR 45.3/100
  • CLAIMS-RICH 17.5 claims/avg
  • TYPE-USCORP US Corporation
  • SPAN-YRS 2020–2024 · 5y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Mitsubishi Chemical UK Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Molecule’s 45.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Molecule

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Molecule's Innovation Score is 45.3/100 (top 23% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Molecule?

Each dot is one of Molecule’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Molecule’s own 17.5 claims/patent is ABOVE the 16.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Molecule vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 12.912.91313.1 1416182022 Granted patents (volume) Avg claims / patent Mitsubishi Chemical UK Limited - 13, 19.77Mitsubishi Chemic…Mitsubishi Electric Power Products, Inc. - 13, 16.62Mitsubishi Electr…Mixed-Signal Devices Inc. - 13, 15.69Mixed-signal Devi…Mohamed bin Zayed University of Artificial Intelligence - 13, 18.92Mohamed bin Zayed…Monogram Biosciences, Inc. - 13, 14.92Monogram Bioscien…Monster Worldwide, Inc. - 13, 20.31Monster WorldwideMorse Micro Pty. Ltd. - 13, 16.23Morse Micro PtyMotedata Corporation - 13, 15.08MotedataMolecule Works Inc. - 13, 17.54Molecule Works
Molecule vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Molecule's grants concentrate

Molecule Works Inc. is a focused PatentsView assignee: 18 CPC subclasses with 69.2% of grants classified under B01D (Separation). Peak complete grant year is 2022 (5 grants) versus a trough of 1 in 2024. By volume, Molecule sits between Mitsubishi Chemical UK Limited and Motedata Corporation.

Molecule's three-year grant acceleration

Molecule Works Inc. shows 8 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Molecule's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Molecule holds 13 patents at rank #21,474, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Molecule

By rank, the assignees closest to #21,474 in granted patent volume.

Leaders in B01D (Separation)

Other assignees with the most granted patents in Molecule's primary technology class.

Molecule's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 23% higher than 77% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 20202021202220232024 1
USPTO utility patent grants by year · 2020–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table
Molecule Works Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2020 2 15.4%
2021 3 23.1%
2022 5 38.5%
2023 2 15.4%
2024 1 7.7%

Which technologies does Molecule Works Inc. patent most?

Top 15 of 18 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Molecule Works Inc.'s patent record in context - here's where to go next.

  • Molecule Works Inc.'s lead technology class is B01D (Separation), 69.2% of its portfolio - see every assignee active in that class. Explore B01D
  • Ranked #21,469 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Molecule Works Inc. against Mitsubishi Chemical UK Limited, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 45.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.